Patents by Inventor Emily Anderson

Emily Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240067983
    Abstract: A novel gRNA-ligand binding complex is provided. This complex may be used to bring Type V Cas proteins and additional effectors to DNA for base editing. The design of the systems allows for the production of efficient modular components that provide flexibility when editing DNA.
    Type: Application
    Filed: January 5, 2022
    Publication date: February 29, 2024
    Inventors: Kurt Daniel Marshall, Hide Bueno Machado, Emily Anderson, Alexander Hale, Amanda Smith, Anastasia Kaufman, Leah Nantie, Michael Daniel Rushton, Kevin Hemphill
  • Publication number: 20210217522
    Abstract: Systems and methods including analyzing profiles, generating recommendation(s) and supporting evidence associated with the recommendation(s) related to medical services provided to a patient, and transmitting the recommendation(s) and supporting evidence associated with the recommendation(s) to a device that displays the information are disclosed. The supporting evidence may be presented based on a statistical relevance of the information and/or a likelihood that a medical professional will utilize the information.
    Type: Application
    Filed: January 14, 2020
    Publication date: July 15, 2021
    Inventors: Peter Vladimir Loscutoff, Christopher James Lauinger, Melanie Goetz, Robert Tristan Williams, Emily Anderson
  • Patent number: 8924303
    Abstract: The embodiments disclosed herein include new, more efficient ways to request, create, send, and receive product reviews from the Internet. One aspect of the invention is an email message for a customer. The email message includes a request to review a product obtained by the customer in a transaction; a rating input area and/or a text input area; an authentication token that includes a transaction identifier corresponding to the transaction; and an HTTP form submission command to send a response to the request from the customer to a remote computer. The response includes a rating entered in the rating input area and/or text entered in the text input area, and the authentication token.
    Type: Grant
    Filed: December 21, 2010
    Date of Patent: December 30, 2014
    Assignee: Google Inc.
    Inventors: Amy Chang, Jan Matthias Ruhl, Todd Jackson, Arturo Crespo, Twum Djin, Emily Anderson
  • Patent number: 8809514
    Abstract: Provided herein are tripartite oligonucleotide complexes which can be administered to a cell, tissue or organism to silence a target gene. The tripartite oligonucleotide complexes of the disclosure may include a conjugate moiety that facilitates delivery to a cell, tissue or organism without the aid of a transfection reagent.
    Type: Grant
    Filed: September 20, 2007
    Date of Patent: August 19, 2014
    Assignee: GE Healthcare Dharmacon, Inc.
    Inventors: Christina Yamada, Anastasia Khvorova, Rob Kaiser, Emily Anderson, Devin Leake
  • Publication number: 20140066595
    Abstract: Cell-free extracts, methods for producing these extracts, methods for using these extracts, compositions that facilitate production of these extracts and kits that contain these extracts are provided. By increasing or decreasing certain gene products through, for example, the use of siRNA or mimics, one can develop mammalian cell-free extracts that have desired levels of efficiency.
    Type: Application
    Filed: August 26, 2013
    Publication date: March 6, 2014
    Applicant: THERMO FISHER SCIENTIFIC BIOSCIENCES INC.
    Inventors: Emily Anderson, Peter Bell, Penny Jensen, Jon Karpilow, Anja Smith, Krishna Vattem, Brian Webb, Devin Leake, Alex Medford, Elena Maksimova, Craig Smith
  • Patent number: 8501706
    Abstract: Provided herein are duplex oligonucleotide complexes which can be administered to a cell, tissue or organism to silence a target gene without the aid of a transfection reagent(s). The duplex oligonucleotide complexes of the disclosure include a conjugate moiety that facilitates delivery to a cell, tissue or organism.
    Type: Grant
    Filed: July 19, 2012
    Date of Patent: August 6, 2013
    Assignee: Dharmacon, Inc.
    Inventors: Christina Yamada, Anastasia Khvorova, Rob Kaiser, Emily Anderson, Devin Leake
  • Publication number: 20120322855
    Abstract: Provided herein are duplex oligonucleotide complexes which can be administered to a cell, tissue or organism to silence a target gene without the aid of a transfection reagent(s). The duplex oligonucleotide complexes of the disclosure include a conjugate moiety that facilitates delivery to a cell, tissue or organism.
    Type: Application
    Filed: July 19, 2012
    Publication date: December 20, 2012
    Applicant: DHARMACON, INC.
    Inventors: Christina Yamada, Anastasia Khvorova, Robert J. Kaiser, Emily Anderson, Devin Leake
  • Patent number: 8252755
    Abstract: Provided herein are duplex oligonucleotide complexes which can be administered to a cell, tissue or organism to silence a target gene without the aid of a transfection reagent(s). The duplex oligonucleotide complexes of the disclosure include a conjugate moiety that facilitates delivery to a cell, tissue or organism.
    Type: Grant
    Filed: September 20, 2007
    Date of Patent: August 28, 2012
    Assignee: Dharmacon, Inc.
    Inventors: Christina Yamada, Anastasia Khvorova, Rob Kaiser, Emily Anderson, Devin Leake
  • Patent number: 8245895
    Abstract: A retaining and cutting device for positioning a leading edge of material at one end of a roll and for puncturing and severing the material a pre-determined distance from the leading edge after removing from the roll, the retaining device comprising elongated jaw members pivotally connected together, a closure member normally urging the jaw members together, and a cutter along one edge of at least one of the jaw members. Extensions of the jaw members are manually grasped to urge the jaw members into an open position for insertion of the next leading edge of material therebetween. The device may also be utilized as a cutting tool for opening sealed boxes and the like.
    Type: Grant
    Filed: December 30, 2008
    Date of Patent: August 21, 2012
    Inventor: Emily Anderson Kelly
  • Publication number: 20110160285
    Abstract: Disclosed herein are a collection of miRNAs and genes whose expression is altered in hypertrophic cardiomyopathy. Accordingly, these miRNAs and genes, singly or in combination, are useful as molecular markers for diagnosis or prognosis of hypertrophic cardiomyopathy. The miRNAs and genes disclosed can also be therapeutic targets for cardiac hypertrophy. For example, agents such as miRNA mimics, miRNA inhibitors or siRNAs for a given miRNA or gene can be used to modulate the level of these molecules thereby inhibiting or preventing hypertrophic cardiomyopathy.
    Type: Application
    Filed: March 12, 2009
    Publication date: June 30, 2011
    Applicants: THE REGENTS OF THE UNIVERSITY OF COLORADO, Dharmacon, Inc.
    Inventors: Emily Anderson, Anastasia Khvorova, Anita G. Seto, Scott Baskerville, Leslie Leinwand, Kevin G. Sullivan
  • Publication number: 20110093393
    Abstract: The embodiments disclosed herein include new, more efficient ways to request, create, send, and receive product reviews from the Internet. One aspect of the invention is an email message for a customer. The email message includes a request to review a product obtained by the customer in a transaction; a rating input area and/or a text input area; an authentication token that includes a transaction identifier corresponding to the transaction; and an HTTP form submission command to send a response to the request from the customer to a remote computer. The response includes a rating entered in the rating input area and/or text entered in the text input area, and the authentication token.
    Type: Application
    Filed: December 21, 2010
    Publication date: April 21, 2011
    Inventors: Amy Chang, Jan Matthias Ruhl, Todd Jackson, Arturo Crespo, Twum Djin, Emily Anderson
  • Patent number: 7860803
    Abstract: The embodiments disclosed herein include new, more efficient ways to request, create, send, and receive product reviews from the Internet. One aspect of the invention is an email message for a customer. The email message includes a request to review a product obtained by the customer in a transaction; a rating input area and/or a text input area; an authentication token that includes a transaction identifier corresponding to the transaction; and an HTTP form submission command to send a response to the request from the customer to a remote computer. The response includes a rating entered in the rating input area and/or text entered in the text input area, and the authentication token.
    Type: Grant
    Filed: February 15, 2006
    Date of Patent: December 28, 2010
    Assignee: Google Inc.
    Inventors: Amy Chang, Jan Matthias Ruhl, Todd Jackson, Arturo Crespo, Twum Djin, Emily Anderson
  • Publication number: 20100093085
    Abstract: Provided herein are tripartite oligonucleotide complexes which can be administered to a cell, tissue or organism to silence a target gene.
    Type: Application
    Filed: September 20, 2007
    Publication date: April 15, 2010
    Applicant: DHARMACON, INC
    Inventors: Christina Yamada, Anastasia Khvorova, Rob Kaiser, Emily Anderson, Devin Leake
  • Publication number: 20090280567
    Abstract: RNA molecules, including siRNA molecules and related control, trackability and exaequo agents with specific stability modifications are provided. These molecules are particularly advantageous as transfection control reagents. The molecules include first and second 5? terminal sense nucleotides with 2?-O-alkyl groups and a label on the first 5? terminal sense nucleotide, in conjunction with at least one additional 2?-O-alkyl pyrimidine modified sense nucleotide, and either: (i) at least one 2? fluoro modified pyrimidine antisense nucleotide and a phosphorylated first 5? terminal antisense nucleotide; or (ii) a first and second 5? terminal antisense nucleotide with 2?-O-alkyl modifications and at least one additional 2?-O-alkyl pyrimidine modified antisense nucleotide.
    Type: Application
    Filed: June 17, 2009
    Publication date: November 12, 2009
    Applicant: DHARMACON, INC.
    Inventors: Devin Leake, Anastasia Khvorova, Yuriy Fedorov, Michael Owen Delaney, Barbara Robertson, Emily Anderson, Angela Reynolds
  • Publication number: 20080085869
    Abstract: Provided herein are duplex oligonucleotide complexes which can be administered to a cell, tissue or organism to silence a target gene without the aid of a transfection reagent(s). The duplex oligonucleotide complexes of the disclosure include a conjugate moiety that facilitates delivery to a cell, tissue or organism.
    Type: Application
    Filed: September 20, 2007
    Publication date: April 10, 2008
    Applicant: Dharmacon, Inc.
    Inventors: Christina Yamada, Anastasia Khvorova, Robert Kaiser, Emily Anderson, Devin Leake
  • Publication number: 20080009012
    Abstract: The present disclosure provides methods, libraries and computer program products for determining whether a phenotype induced by a candidate siRNA for a target gene in an RNAi experiment is target specific or a false positive. Through the use of a control siRNA that has one or two seed sequences of six or seven bases in combination with a neutral scaffolding sequence, a distinction can be made between false positive and true positive analyses of functionality.
    Type: Application
    Filed: July 6, 2007
    Publication date: January 10, 2008
    Applicant: DHARMACON, INC.
    Inventors: Amanda Birmingham, Emily Anderson, Angela Reynolds, Devin Leake, Scott Baskerville, Yuriy Fedorov, Jon Karpilow, William Marshall, Anastasia Khvorova
  • Publication number: 20070269889
    Abstract: RNA molecules, including siRNA molecules and related control, trackability and exaequo agents with specific stability modifications are provided. These molecules are particularly advantageous as transfection control reagents. The molecules include first and second 5? terminal sense nucleotides with 2?-O-alkyl groups and a label on the first 5? terminal sense nucleotide, in conjunction with at least one additional 2?-O-alkyl pyrimidine modified sense nucleotide, and either: (i) at least one 2? fluoro modified pyrimidine antisense nucleotide and a phosphorylated first 5? terminal antisense nucleotide; or (ii) a first and second 5? terminal antisense nucleotide with 2?-O-alkyl modifications and at least one additional 2?-O-alkyl pyrimidine modified antisense nucleotide.
    Type: Application
    Filed: February 4, 2005
    Publication date: November 22, 2007
    Applicant: DHARMACON, INC.
    Inventors: Devin Leake, Anastasia Khvorova, Yuriy Fedorov, Michael Delaney, Barbara Robertson, Emily Anderson, Angela Reynolds
  • Publication number: 20070218495
    Abstract: The present invention provides methods, libraries and computer program products for selecting siRNA that reduce off-target effects and methods for gene silencing using these siRNAs. By comparing nucleotide sequences at positions 2-7 or 2-8 of the sense and/or antisense regions of candidate siRNAs to the 3? UTR region of mRNAs, one can select siRNAs that have reduced off-target effects.
    Type: Application
    Filed: March 15, 2007
    Publication date: September 20, 2007
    Applicant: Dharmacon, Inc.
    Inventors: Amanda Birmingham, Emily Anderson, Angela Reynolds, Devin Leake, Scott Baskerville, Yuriy Fedorov, Jon Karpilow, William Marshall, Anastasia Khvorova
  • Patent number: 7158499
    Abstract: A method and apparatus for communicating audio messages uses a two-way radio. An output audio message is asynchronously transmitted by generating a first acoustic signal in an input device of the radio. A determination is made whether the first acoustic signal is a command. If the acoustic signal is a command, then a response is generated in an output device, and the command is processed. Otherwise, the first acoustic signal is stored in an output buffer and then later sent as an output audio message only when a communications channel is available. An input audio message is asynchronously received in a receiver of the radio, and then stored in an input buffer. A second acoustic signal is generated which causes the stored input audio message to be sent to the output device only if the second acoustic signal is a play command.
    Type: Grant
    Filed: September 19, 2001
    Date of Patent: January 2, 2007
    Assignee: Mitsubishi Electric Research Laboratories, Inc.
    Inventors: David B. Anderson, Emily Anderson, Barry Perlman
  • Publication number: 20060211004
    Abstract: Methods and compositions for determining cytotoxicity of a transfection agent are provided. In one aspect, a cell is contacted with a transfection agent. Following contact, a cytotoxic marker profile of the cell is evaluated to determine whether the transfection agent has mediated a cytotoxic response in the cell. Also provided are compositions and reagents, and kits for practicing the subject methods. The subject methods and compositions find use in a variety of different applications.
    Type: Application
    Filed: June 10, 2005
    Publication date: September 21, 2006
    Inventors: Diane Ilsley, Arindam Bhattacharjee, Emily Anderson, Anastasia Khvorova